Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms
- 25 October 2017
- journal article
- research article
- Published by Georg Thieme Verlag KG in Klinische Padiatrie
- Vol. 229 (06) , 329-334
Abstract
Individuals with Fanconi anemia (FA) have a high risk of developing myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), yet the secondary somatic mutations lending to these malignancies remain to be further elucidated. We employed a next-generation sequencing myeloid neoplasia gene panel to determine the mutational spectrum of FA-related MDS/AML. Ten of 16 patients showed missense, nonsense, insertion or duplication mutations in 13 genes. In contrast to findings in MDS in the general population, mutations in genes involved in RNA splicing were rarely affected. Mutations in RUNX1 and genes of the RAS pathway appeared more instrumental in the pathogenesis of FA myeloid malignancies. RUNX1 mutations were associated with more advanced disease. Interestingly, one patient with refractory anemia with ring sideroblasts harbored the SF3B1 p.K700E mutation highlighting the mutation’s causative role in MDS with ring sideroblasts even in the context of FA. On the whole, our findings implicate a different genetic architecture of FA MDS/AML from adult sporadic MDS. Notably, the genetic events resemble those described in pediatric MDS. Individuen mit Fanconi-Anämie (FA) haben ein hohes Risiko, ein myelodysplastisches Syndrom (MDS) oder eine akute myeloische Leukämie (AML) zu entwickeln, doch die sekundären somatischen Mutationen, die diesen Neoplasien zugrunde liegen, sind weitgehend unklar. Wir führten die Sequenzanalyse eines Multigen-Panels für myeloische Neoplasien durch, um das Mutationsspektrum von FA-assoziiertem MDS/AML zu untersuchen. Zehn von 16 FA/MDS bzw. FA/AML Patienten zeigten somatische Missense-, Nonsense-, Insertions- oder Duplikationsmutationen in 13 Genen. Im Gegensatz zum Mutationsspektrum beim sporadischen MDS waren Mutationen in Genen für RNA-Spleißen selten. Mutationen in RUNX1 und Genen des RAS-Signalweges waren in der Pathogenese von FA assoziierten myeloischen Neoplasien bedeutsamer. RUNX1-Mutationen waren mit fortgeschrittenem MDS assoziiert. Interessanterweise zeigte ein Patient mit refraktärer Anämie mit Ring-Sideroblasten eine SF3B1-Mutation, was die Bedeutung dieser Mutationen beim MDS mit Ring-Sideroblasten selbst im FA Kontext hervorhebt. Unsere Ergebnisse implizieren eine genetische Architektur des FA assoziierten MDS/AML, welches dem pädiatrischen MDS ähnelt und sich von adulten MDS unterscheidet. * Shared first authorshipKeywords
This publication has 25 references indexed in Scilit:
- Clonal diversity of recurrently mutated genes in myelodysplastic syndromesLeukemia, 2013
- The role of mutations in epigenetic regulators in myeloid malignanciesNature Reviews Cancer, 2012
- RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genesHaematologica, 2012
- Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMMLBlood, 2012
- SomaticSF3B1Mutation in Myelodysplasia with Ring SideroblastsNew England Journal of Medicine, 2011
- Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesionsBlood, 2011
- Mutations of ASXL1 gene in myeloproliferative neoplasmsLeukemia, 2009
- RUNX1 gene mutation in primary myelodysplastic syndrome – the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcomeBritish Journal of Haematology, 2007
- Somatic PTPN11 mutations in childhood acute myeloid leukaemiaBritish Journal of Haematology, 2005
- A 20-year perspective on the International Fanconi Anemia Registry (IFAR)Blood, 2003